GULP1: New hope for hepatocellular carcinoma: Reply to correspondence on "GULP1 as a novel diagnostic and predictive biomarker in hepatocellular carcinoma"

Affiliations

Comment

Yuhao Xie et al. Clin Mol Hepatol. 2026 Jan.

. 2026 Jan;32(1):e112-e114.

doi: 10.3350/cmh.2025.0415. Epub 2025 Apr 28.

¹ Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St John's University, Queens, NY, USA.

No abstract available

Keywords: Biomarker; GULP1 protein; Hepatocellular carcinoma.

Conflict of interest statement

Conflicts of Interest

The authors have no conflicts to disclose.

Correspondence to editorial on "GULP1 as a novel diagnostic and predictive biomarker in hepatocellular carcinoma".
Kim SS, Kim HS, Cheong JY, Eun JW. Kim SS, et al. Clin Mol Hepatol. 2026 Jan;32(1):e72-e74. doi: 10.3350/cmh.2025.0350. Epub 2025 Apr 4. Clin Mol Hepatol. 2026. PMID: 40181674 Free PMC article. No abstract available.

1. Kim HS, Yoon JH, Choi JY, Yoon MG, Baek GO, Kang M, et al. GULP1 as a novel diagnostic and predictive biomarker in hepatocellular carcinoma. Clin Mol Hepatol. 2025;31:914–934. - PMC - PubMed
1. Xie Y, Cao LQ, Wurpel J, Chen ZS. GULP1, a multifaceted diagnostic biomarker and potential therapeutic target in hepatocellular carcinoma: Editorial on “GULP1 as a novel diagnostic and predictive biomarker in hepatocellular carcinoma”. Clin Mol Hepatol. 2026;32:413–415. - PMC - PubMed
1. Kim SS, Kim HS, Cheong JY, Eun JW. Correspondence to editorial on “GULP1 as a novel diagnostic and predictive biomarker in hepatocellular carcinoma”. Clin Mol Hepatol. 2026;32:e72–e74. - PubMed
1. Gong J, Gaitanos TN, Luu O, Huang Y, Gaitanos L, Lindner J, et al. Gulp1 controls Eph/ephrin trogocytosis and is important for cell rearrangements during development. J Cell Biol. 2019;218:3455–3471. - PMC - PubMed
1. Hayashi M, Guida E, Inokawa Y, Goldberg R, Reis LO, Ooki A, et al. GULP1 regulates the NRF2-KEAP1 signaling axis in urothelial carcinoma. Sci Signal. 2020;13:eaba0443. - PubMed